Alphapharm
Alphapharm is an Australian generic and branded pharmaceutical manufacturer and distributor, operating since 1982 as part of Viatris Inc., producing 1,000+ registered products across multiple therapeutic areas and serving Australian patients, healthcare professionals, and the federal PBS programme.
- Company typePublic
- Founded2020
- HeadquartersSydney, Australia
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Alphapharm does
Alphapharm is an Australian pharmaceutical manufacturer and distributor founded in 1982 and headquartered in Sydney, operating today as the Australian arm of Viatris Inc. (NASDAQ: VTRS) following its 2014 acquisition by Mylan and subsequent integration into Viatris through the November 2020 merger of Mylan and Pfizer's Upjohn division. The company produces and distributes a broad portfolio of generic and branded medicines, with over 1,000 registered products in Australia spanning multiple therapeutic areas and approximately 450 formulations globally. Manufacturing scale is substantial at 4 billion annual doses, with Australian-made medicines accounting for roughly one in three Viatris products supplied to Australian patients. Distribution is anchored by a direct Queensland warehouse handling 900 of the registered products domestically, complemented by export channels reaching more than 40 countries.
The business operates primarily through a B2B healthcare channel model rather than direct-to-consumer, with revenue derived from pharmaceutical product sales under Australia's Pharmaceutical Benefits Scheme (PBS) pricing framework. Key customer segments include Australian doctors, pharmacists, health professional organisations, the Federal Government through PBS partnerships, and patient groups, with ~800 employees supporting operations. The go-to-market is sales-led, leveraging professional relationships and education initiatives rather than consumer marketing, with complementary engagement through LinkedIn, Instagram, YouTube, X (Twitter), the corporate newsroom, and the Viatris Connect partner portal. The value proposition centres on affordable access to high-quality medicines regardless of geography or circumstance, underpinned by the scale of local manufacturing and the breadth of the global Viatris portfolio spanning 1,400+ molecules.
Alphapharm firmographics
Firmographics- Name
- Alphapharm
- Legal name
- Viatris Inc.
- Website
- https://alphapharm.com.au
- Company type
- Public
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Alphapharm is an Australian generic and branded pharmaceutical manufacturer and distributor, operating since 1982 as part of Viatris Inc., producing 1,000+ registered products across multiple therapeutic areas and serving Australian patients, healthcare professionals, and the federal PBS programme.
- Ownership category
- akta.pro rank
Alphapharm industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Generic Hospital & Institutional Products (HLAIABAL), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
Keywords
Where Alphapharm is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Alphapharm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Sale of generic and branded pharmaceutical medicines across 1,000+ registered products in Australia, with 900 products delivered through direct warehouse distribution in Queensland
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Alphapharm product offering
Product offeringCore offering
Alphapharm, operating as Viatris Australia, manufactures and distributes a broad portfolio of generic and branded pharmaceutical medicines in Australia. The company offers over 1,000 registered products across multiple therapeutic areas, with 450+ formulations and 4 billion annual dose capacity, delivering 900 products directly through its Queensland warehouse and exporting to 40+ countries.
Product overview
Viatris Australia operates as a pharmaceutical company within the Viatris global network, producing and distributing a broad range of high-quality medicines. The company offers over 1,000 registered products in Australia across various therapeutic areas, with approximately 900 products delivered through their Queensland warehouse. Their global portfolio spans more than 1,400 molecules. The company emphasizes access to medicines regardless of geography or circumstance, with about one-third of medicines supplied to Australian patients being Australian-made. No specific named product brands or modules are detailed in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Viatris Australia Pharmaceutical Medicines Portfolio
Quantifiable outcome
- Approximately 1 in 3 Viatris medicines supplied to Australian patients are Australian made
- +1 more outcomes
Companies that use Alphapharm
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles3 records
Alphapharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Alphapharm partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Doctors and Healthcare ProfessionalscorePartnerships with doctors and healthcare professionals across Australia to provide access to a broad range of medicines and support education on appropriate medicine use
- Pharmacists and Pharmacy NetworkscorePartnerships with pharmacists and pharmacy networks for medicine dispensing and patient education on appropriate medicine use
- Health Professional OrganisationscoreStrategic partnerships with health professional organisations to support better health outcomes for Australians through medicine access and education
- Australian Federal GovernmentcorePartnership with Federal Government for supply of affordable medicines through PBS (Pharmaceutical Benefits Scheme)
- Patient GroupscorePartnerships with patient groups to help bring affordable medicines to Australians and support education on appropriate use
- Business PartnersminorPartnerships with other business partners in Australia to help bring affordable medicines to Australians
Scale indicators7 records
Recent moves4 records
Expansion highlights5 records
Alphapharm competitors and assessment
Company assessmentDirect peers
- Sandoz (Novartis): Global leader in generic pharmaceuticals and biosimilars spun out from Novartis. Directly comparable to Alphapharm as a large-scale generic finished dosage form manufacturer serving global markets including Australia with similar product breadth and PBS participation.
- Teva Pharmaceutical Industries: World's largest generic drug manufacturer with extensive portfolio of finished dosage forms across all therapeutic areas. Operates in Australia and competes head-to-head with Alphapharm in PBS generic categories.
- Apotex: Canadian-headquartered generic pharmaceutical manufacturer with significant global operations including Australia. Competes directly with Alphapharm in generic finished dosage forms across multiple therapeutic categories.
- Mayne Pharma: Australian-headquartered specialty and generic pharmaceutical company with manufacturing operations in Australia. Directly comparable as a domestic Australian generic manufacturer serving PBS with overlapping therapeutic areas.
- Aurobindo Pharma: India-headquartered global generic pharmaceutical manufacturer with significant Australian presence and PBS registrations. Competes with Alphapharm on price and scale across generic categories supplied to the Australian market.
- Dr. Reddy's Laboratories: India-based global generic pharmaceutical manufacturer with Australian operations and PBS-listed products. Directly comparable as a large-scale generic finished dosage form manufacturer targeting Australia.
- Lupin Pharmaceuticals: India-headquartered global generic pharmaceutical manufacturer with Australian commercial presence. Comparable as a competitor in generic finished dosage forms across therapeutic categories including those supplied under PBS.
- Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company, formed through mergers of several Australian generics businesses. Direct head-to-head competitor to Alphapharm in PBS generic categories with comparable scale and therapeutic area coverage.
Regional players
- Aspen Pharmacare: South African-headquartered multinational pharmaceutical company with presence in Australia and other markets. Operates as a generic and specialty manufacturer serving similar healthcare markets to Alphapharm, though primarily focused on African and other geographies.
- Sigma Healthcare: Australian pharmaceutical wholesale and distribution business serving community pharmacies. Adjacent comparable as part of the Australian pharmaceutical supply chain, though primarily a distributor rather than manufacturer like Alphapharm.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Alphapharm social profiles
Digital presenceAlphapharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alphapharm leadership team
Management profileNumber of profiles
Profiles1 record
Alphapharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alphapharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alphapharm
What does Alphapharm do?
Alphapharm, operating as Viatris Australia, manufactures and distributes a broad portfolio of generic and branded pharmaceutical medicines in Australia. The company offers over 1,000 registered products across multiple therapeutic areas, with 450+ formulations and 4 billion annual dose capacity, delivering 900 products directly through its Queensland warehouse and exporting to 40+ countries.
Is Alphapharm a public or private company?
Alphapharm is a public company. It is classified as public and is currently operating.
When was Alphapharm founded?
Alphapharm was founded in 2020. It employs 501 to 1,000 people.
Where is Alphapharm based?
Alphapharm is headquartered in Sydney, Australia, in the Oceania region.
How does Alphapharm make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Alphapharm's main competitors?
Direct peers on record are Sandoz (Novartis), Teva Pharmaceutical Industries, Apotex, Mayne Pharma, Aurobindo Pharma, Dr. Reddy's Laboratories, Lupin Pharmaceuticals and Arrotex Pharmaceuticals. Regional players are Aspen Pharmacare and Sigma Healthcare.
Does Alphapharm have an API?
No public API is recorded for Alphapharm.
What industry is Alphapharm in?
Alphapharm's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.